Autor: |
Rui Yang, Yu-Bin Fu, Xin-Bao Li, Ru Ma, Yan-Dong Su, He-Liang Wu, Xin-Li Liang, Yan Li |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-7 (2023) |
Druh dokumentu: |
article |
ISSN: |
1477-7819 |
DOI: |
10.1186/s12957-023-03232-1 |
Popis: |
Abstract Background As the standard treatment for pseudomyxoma peritonei (PMP), cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly prolong the survival of PMP patients, and some patients can even achieve long-term survival (LTS) or clinical cure. The purpose of this study was to analyze the clinicopathological and treatment features of PMP patients with LTS and to explore the survival benefit factors of PMP patients. Methods The clinicopathological and prognostic data of PMP patients who received CRS + HIPEC at our center from December 2004 to May 2023 were retrospectively analyzed. PMP patients were divided into LTS group (≥ 10 years) and short-term survival (STS) group ( |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|